Global RNA analysis market
DUBLIN, April 19, 2024 (Globe Newswire) — The “RNA Analysis Market – Global Industry Size, Share, Trends, Opportunities, and Forecasts, 2018-2028” report has been added. ResearchAndMarkets.com Recruitment.
The global RNA analysis market has shown a phenomenal rise, increasing the market valuation to USD 7.45 billion in 2022 and is expected to maintain a stable growth trajectory from 2018 to 2028. Due to the focus on personalized medicine, this market segment is expected to expand significantly.
As a central aspect of molecular biology and genomics, RNA analysis provides valuable insight into the structure, function, and regulatory mechanisms of RNA molecules. At a CAGR of 9%, the industry's growth is being driven by innovations in next-generation sequencing (NGS) and single-cell RNA-seq (scRNA-seq), which are increasing the accuracy and cost of RNA-based tests. has been reduced.
Advances in RNA sequencing drive global market growth
Breakthrough improvements in platforms such as Illumina's HiSeq and NovaSeq have enhanced the capabilities of RNA-Seq, allowing researchers to analyze a wide range of RNA molecules. At the same time, long-read sequencing technologies such as SMRT sequencing and nanopore sequencing have emerged as pivotal tools for studying complex gene structures and alternative splicing phenomena. Advances in this field are also seen in the growing repertoire of sample preparation techniques that enable RNA analysis from rare resources such as clinical biopsies. This versatility is key to facilitating the widespread adoption of RNA analysis across a variety of fields, from agriculture to personalized medicine.
At the forefront: RNA analysis in oncology and agriculture
In the field of oncology research, RNA analysis is essential for identifying cancer biomarkers and facilitating the development of targeted therapies. The urgent need to address the global cancer epidemic is driving significant demand for these advanced diagnostic tools. At the same time, in agriculture, RNA analysis is at the heart of uncovering the genes that contribute to traits such as disease resistance and drought tolerance, thereby supporting the evolution of resilient crop varieties. This important application in enhancing food security will strongly propel the global RNA analysis market.
Single-cell RNA sequencing challenges hinder market progress
Despite robust expansion, the complexity of single-cell RNA sequencing poses significant challenges, ranging from managing high-dimensional data to maintaining sample quality. Overcoming these obstacles is critical to realizing the full potential of RNA analysis in scientific discovery and clinical applications.
Bioinformatics and data analysis: The pulse of RNA analysis
The flood of RNA-Seq data highlights the need for advanced bioinformatics tools for data preprocessing and quality control. Algorithm enhancements are critical in the fight against large amounts of genetic information, making it easier to align, annotate, and interpret RNA-Seq data for actionable insights.
Advantages of kits and reagents and qPCR technology
In the world of products, kits and reagents maintain their place and are preferred for standardization and reliability in research laboratories. Similarly, the qPCR segment, known for its precision and versatility, is leading the technological frontier and underpins a myriad of RNA analysis operations, including pathogen detection and microRNA profiling.
Infectious diseases drive market demand
In line with pressing global health challenges, the field of infectious diseases and pathogenesis has emerged as a major contributor to the market. The continued management of pandemics like the coronavirus disease (COVID-19) has highlighted the critical role that RNA analysis plays in monitoring and mitigating infectious disease threats, strengthening the market trajectory.
North America leads regional market share
Backed by a strong scientific research infrastructure and active pharmaceutical sector, North America is a prominent region in the global RNA analysis market. Popularity in this region is believed to be due to a combination of technological capabilities, significant research funding, and a comprehensive regulatory environment that facilitates RNA-based investigations.
key attributes
report attributes |
detail |
number of pages |
180 |
Forecast period |
2022-2028 |
Estimated market value in 2022 (USD) |
$7.45 billion |
Projected market value to 2028 (USD) |
$12.45 billion |
compound annual growth rate |
9% |
Target area |
global |
Companies mentioned in this report include, but are not limited to:
-
Agilent Technologies Co., Ltd.
-
F. Hoffman La Roche AG
-
Illumina Co., Ltd.
-
Qiagen
-
Thermo Fisher Scientific
-
eurofins scientific
-
Merck KGaA
-
Bio-Rad Laboratories, Inc.
-
Pacific Biosciences of California, Inc.
-
Affymetrix Co., Ltd.
For more information on this report, please visit https://www.researchandmarkets.com/r/msd4co.
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.
attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900